Inhaled Management of COPD
This section of the Learning Zone aims to provide you with information to help you decide which treatments options are suitable for your patients. Topics include:
- Goals of treatment
- Non-pharmacological intervention options
- Pharmacological intervention options
- Muscarinic antagonists
Since its first annual report in 1997, the Global initiative for chronic Obstructive Lung Disease (GOLD) has sought to provide recommendations for the management of COPD based on the best scientific information available. Its aim has been a non-biased review for the practising clinician to aid in the assessment, diagnosis and treatment of patients with COPD.
Considerations in Women
This section within COPD and its Management aims to provide information surrounding the management of COPD in women.
Treatment options references
- Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2020. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.; 2020. www.goldcopd.org. Accessed November 25, 2019.
- Kuyucu T, Güçlü SZ, Şaylan B, et al. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study. Tuberc Thorax. 2011;59(4):328-339.
Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-1413.
Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5 SUPPL.):4S-42S.